129 related articles for article (PubMed ID: 38867938)
1. HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus-associated cancers.
Liu L; Xie Y; Yang H; Lin A; Dong M; Wang H; Zhang C; Liu Z; Cheng Q; Zhang J; Yuan S; Luo P
Imeta; 2023 Aug; 2(3):e130. PubMed ID: 38867938
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of significant genes and immune cell infiltration in HPV-related head and neck squamous cell carcinoma.
Xu L; Jin Y; Qin X
Int Immunopharmacol; 2020 Oct; 87():106844. PubMed ID: 32738592
[TBL] [Abstract][Full Text] [Related]
3. OralExplorer: a web server for exploring the mechanisms of oral inflammatory diseases.
Lin W; Yang H; Lin J; Yang X; Liao Z; Zheng Y; Luo P; Liu C
J Transl Med; 2024 Mar; 22(1):282. PubMed ID: 38491529
[TBL] [Abstract][Full Text] [Related]
4. The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis.
Salnikov M; Gameiro SF; Zeng PYF; Barrett JW; Nichols AC; Mymryk JS
mSphere; 2022 Aug; 7(4):e0031722. PubMed ID: 35950764
[TBL] [Abstract][Full Text] [Related]
5. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
[TBL] [Abstract][Full Text] [Related]
6. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the Association between HPV and Pan-Cancers: A Bidirectional Two-Sample Mendelian Randomization Study.
Sun J; Xiang J; An Y; Xu J; Xiong Y; Wang S; Xia Q
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958321
[TBL] [Abstract][Full Text] [Related]
8. Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers.
Saulters EL; Kennedy PT; Carter RJ; Alsufyani A; Jones TM; Woolley JF; Dahal LN
Cancer Res Commun; 2024 Jan; 4(1):118-133. PubMed ID: 38147007
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
10. Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.
Zhu X; Li S; Luo J; Ying X; Li Z; Wang Y; Zhang M; Zhang T; Jiang P; Wang X
Front Immunol; 2022; 13():801639. PubMed ID: 35126391
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma.
Alahmadi RM; Marraiki N; Alswayyed M; Khoja HA; Al-Anazi AE; Alahmadi RM; Alkusayer MM; Alosaimi B; Awadalla M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067251
[TBL] [Abstract][Full Text] [Related]
12. The exploration of new therapeutic targets for HPV-negative head and neck squamous cell cancer through the construction of a ceRNA network and immune microenvironment analysis.
Wang Z; Liu T; Li G; Cao Z
J Cell Biochem; 2020 Jun; 121(5-6):3426-3437. PubMed ID: 31898341
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
Mo Z; Li P; Cao Z; Zhang S
Front Immunol; 2021; 12():564948. PubMed ID: 34290693
[TBL] [Abstract][Full Text] [Related]
14. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.
Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667
[No Abstract] [Full Text] [Related]
15. The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
Chen S; Lai H; Zhao J; Chen B; Li Y; Li Y; Li Q; Zheng Q; Huang S; Zhu X
BMC Cancer; 2021 Nov; 21(1):1183. PubMed ID: 34740324
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
19. ExplORRNet: An interactive web tool to explore stage-wise miRNA expression profiles and their interactions with mRNA and lncRNA in human breast and gynecological cancers.
Lawarde A; Sharif Rahmani E; Nath A; Lavogina D; Jaal J; Salumets A; Modhukur V
Noncoding RNA Res; 2024 Mar; 9(1):125-140. PubMed ID: 38035042
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed genes and pathways for risk stratification in HPV-associated cancers governing different anatomical sites.
Kwon EJ; Lee HR; Lee JH; Seo C; Ha M; Roh J; Kim YH; Jang JY
Front Biosci (Landmark Ed); 2022 Jan; 27(1):2. PubMed ID: 35090306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]